116 related articles for article (PubMed ID: 33143554)
1. Development and validation of a Brazilian nomogram to assess sentinel node biopsy positivity in melanoma.
Bertolli E; Calsavara VF; de Macedo MP; Pinto CAL; Duprat Neto JP
Tumori; 2021 Oct; 107(5):440-445. PubMed ID: 33143554
[TBL] [Abstract][Full Text] [Related]
2. Validation of a Nomogram for Non-sentinel Node Positivity in Melanoma Patients, and Its Clinical Implications: A Brazilian-Dutch Study.
Bertolli E; Franke V; Calsavara VF; de Macedo MP; Pinto CAL; van Houdt WJ; Wouters MWJM; Duprat Neto JP; van Akkooi ACJ
Ann Surg Oncol; 2019 Feb; 26(2):395-405. PubMed ID: 30456681
[TBL] [Abstract][Full Text] [Related]
3. Effects of time interval between primary melanoma excision and sentinel node biopsy on positivity rate and survival.
Oude Ophuis CM; van Akkooi AC; Rutkowski P; Voit CA; Stepniak J; Erler NS; Eggermont AM; Wouters MW; Grünhagen DJ; Verhoef CK
Eur J Cancer; 2016 Nov; 67():164-173. PubMed ID: 27669503
[TBL] [Abstract][Full Text] [Related]
4. Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma.
Wagner JD; Gordon MS; Chuang TY; Coleman JJ; Hayes JT; Jung SH; Love C
Cancer; 2000 Jul; 89(2):453-62. PubMed ID: 10918179
[TBL] [Abstract][Full Text] [Related]
5. Prediction of Non-sentinel Node Status in Patients with Melanoma and Positive Sentinel Node Biopsy: An Italian Melanoma Intergroup (IMI) Study.
Rossi CR; Mocellin S; Campana LG; Borgognoni L; Sestini S; Giudice G; Caracò C; Cordova A; Solari N; Piazzalunga D; Carcoforo P; Quaglino P; Caliendo V; Ribero S;
Ann Surg Oncol; 2018 Jan; 25(1):271-279. PubMed ID: 29067603
[TBL] [Abstract][Full Text] [Related]
6. Validation of a nomogram predicting sentinel lymph node status in melanoma in an Irish population.
Woods JF; De Marchi JA; Lowery AJ; Hill AD
Ir J Med Sci; 2015 Dec; 184(4):769-73. PubMed ID: 24997756
[TBL] [Abstract][Full Text] [Related]
7. Improved Risk Prediction Calculator for Sentinel Node Positivity in Patients With Melanoma: The Melanoma Institute Australia Nomogram.
Lo SN; Ma J; Scolyer RA; Haydu LE; Stretch JR; Saw RPM; Nieweg OE; Shannon KF; Spillane AJ; Ch'ng S; Mann GJ; Gershenwald JE; Thompson JF; Varey AHR
J Clin Oncol; 2020 Aug; 38(24):2719-2727. PubMed ID: 32530761
[TBL] [Abstract][Full Text] [Related]
8. A nomogram to predict node positivity in patients with thin melanomas helps inform shared patient decision making.
Friedman C; Lyon M; Torphy RJ; Thieu D; Hosokawa P; Gonzalez R; Lewis KD; Medina TM; Rioth MJ; Robinson WA; Kounalakis N; McCarter MD; Gleisner AL
J Surg Oncol; 2019 Dec; 120(7):1276-1283. PubMed ID: 31602665
[TBL] [Abstract][Full Text] [Related]
9. Predicting sentinel node positivity in patients with melanoma: external validation of a risk-prediction calculator (the Melanoma Institute Australia nomogram) using a large European population-based patient cohort.
El Sharouni MA; Varey AHR; Witkamp AJ; Ahmed T; Sigurdsson V; van Diest PJ; Scolyer RA; Thompson JF; Lo SN; van Gils CH
Br J Dermatol; 2021 Aug; 185(2):412-418. PubMed ID: 33657653
[TBL] [Abstract][Full Text] [Related]
10. Sentinel Node Status is the Most Important Prognostic Information for Clinical Stage IIB and IIC Melanoma Patients.
Fonseca IB; Lindote MVN; Monteiro MR; Doria Filho E; Pinto CAL; Jafelicci AS; de Melo Lôbo M; Calsavara VF; Bertolli E; Duprat Neto JP
Ann Surg Oncol; 2020 Oct; 27(11):4133-4140. PubMed ID: 32767223
[TBL] [Abstract][Full Text] [Related]
11. The interval between primary melanoma excision and sentinel node biopsy is not associated with survival in sentinel node positive patients - An EORTC Melanoma Group study.
Oude Ophuis CM; Verhoef C; Rutkowski P; Powell BW; van der Hage JA; van Leeuwen PA; Voit CA; Testori A; Robert C; Hoekstra HJ; Grünhagen DJ; Eggermont AM; van Akkooi AC
Eur J Surg Oncol; 2016 Dec; 42(12):1906-1913. PubMed ID: 27266406
[TBL] [Abstract][Full Text] [Related]
12. Sentinel node biopsy (SNB) in malignant melanoma as same day procedure vs delayed procedure: clinical and economic outcome.
Rødgaard JC; Kramer S; Stolle LB
J Plast Surg Hand Surg; 2014 Aug; 48(4):265-9. PubMed ID: 24328901
[TBL] [Abstract][Full Text] [Related]
13. Validation and head-to-head comparison of three nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended and/or sentinel lymph node dissection.
Grivas N; Wit E; Tillier C; van Muilekom E; Pos F; Winter A; van der Poel H
Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2213-2226. PubMed ID: 28780722
[TBL] [Abstract][Full Text] [Related]
14. Vertical Growth Phase as a Prognostic Factor for Sentinel Lymph Node Positivity in Thin Melanomas: A Systematic Review and Meta-Analysis.
Appleton SE; Fadel Z; Williams JS; Bezuhly M
Plast Reconstr Surg; 2018 Jun; 141(6):1529-1540. PubMed ID: 29579032
[TBL] [Abstract][Full Text] [Related]
15. Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma.
Doubrovsky A; De Wilt JH; Scolyer RA; McCarthy WH; Thompson JF
Ann Surg Oncol; 2004 Sep; 11(9):829-36. PubMed ID: 15313732
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of melanoma features and their relationship with nodal disease: the importance of the pathological report.
Bertolli E; de Macedo MP; Pinto CA; Damascena AS; Molina AS; Ueno PS; Duprat Neto JP
Tumori; 2015; 101(5):501-5. PubMed ID: 25983100
[TBL] [Abstract][Full Text] [Related]
17. Validation of a nomogram to predict the presence of sentinel lymph node metastases in melanoma.
Piñero A; Canteras M; Ortiz E; Martínez-Barba E; Parrilla P
Ann Surg Oncol; 2008 Oct; 15(10):2874-7. PubMed ID: 18648880
[TBL] [Abstract][Full Text] [Related]
18. Support vector machine learning model for the prediction of sentinel node status in patients with cutaneous melanoma.
Mocellin S; Ambrosi A; Montesco MC; Foletto M; Zavagno G; Nitti D; Lise M; Rossi CR
Ann Surg Oncol; 2006 Aug; 13(8):1113-22. PubMed ID: 16865598
[TBL] [Abstract][Full Text] [Related]
19. Is it Necessary to Perform Sentinel Lymph Node Biopsy in Thin Melanoma? A Retrospective Single Center Analysis.
Kocsis A; Karsko L; Kurgyis Z; Besenyi Z; Pavics L; Dosa-Racz E; Kis E; Baltas E; Ocsai H; Varga E; Bende B; Varga A; Mohos G; Korom I; Varga J; Kemeny L; Nemeth IB; Olah J
Pathol Oncol Res; 2020 Jul; 26(3):1861-1868. PubMed ID: 31792874
[TBL] [Abstract][Full Text] [Related]
20. Sentinel node biopsy for melanoma. Analysis of our experience (125 patients).
Soliveres Soliveres E; García Marín A; Díez Miralles M; Nofuentes Riera C; Candela Gomis A; Moragón Gordon M; Antón Leal MÁ; García García S
Cir Esp; 2014 Nov; 92(9):609-14. PubMed ID: 24365603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
